<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03630523</url>
  </required_header>
  <id_info>
    <org_study_id>NL66559.091.18</org_study_id>
    <nct_id>NCT03630523</nct_id>
  </id_info>
  <brief_title>Response of Immune System to Flu Vaccination in PHTS</brief_title>
  <acronym>RIPS</acronym>
  <official_title>Registering the Immune Response to a Flu Vaccination Challenge in PTEN Hamartoma Tumour Syndrome</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Radboud University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Radboud University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      this study evaluates the cellular and humoral immune response to seasonal influenze&#xD;
      vaccination in PTEN Hamartoma Tumor Syndrome. All subjects will be administered flu&#xD;
      vaccination, half of the subjects will be control subjects.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Not yet recruiting</last_known_status>
  <start_date type="Anticipated">October 2018</start_date>
  <completion_date type="Anticipated">January 2019</completion_date>
  <primary_completion_date type="Anticipated">January 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Hemagglutination inhibition assay titre</measure>
    <time_frame>7 days</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Proliferation assay</measure>
    <time_frame>21 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>interleukin profile</measure>
    <time_frame>21 days, 7 days</time_frame>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">30</enrollment>
  <condition>PTEN Hamartoma Tumor Syndrome</condition>
  <arm_group>
    <arm_group_label>Vaccination</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Arm contains all subjects; vaccination with Influvac Tetra will be administered at start of study, response will be measured in 7 and 21 days.</description>
  </arm_group>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>Influvac Tetra</intervention_name>
    <description>Tetravalent seasonal flu vaccination 2018/2019</description>
    <arm_group_label>Vaccination</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Must be diagnosed with PHTS based on genetic testing&#xD;
&#xD;
          -  Must be a Radboudumc patient&#xD;
&#xD;
          -  Must be 18 years or older&#xD;
&#xD;
          -  Must be mentally competent&#xD;
&#xD;
          -  Must have provided written informed consent to participate in the study&#xD;
&#xD;
          -  Must be able to adhere to visit schedule and available to complete the study&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  â€¢ Known history of significant medical disorder, which in the investigator's judgment&#xD;
             might confound the results of the study or pose additional risk to the subject by&#xD;
             participation in the study&#xD;
&#xD;
               -  Known hypersensitivity to previous influenza vaccinations (Anaphylaxis)&#xD;
&#xD;
               -  Must not be allergic to chicken eggwhite&#xD;
&#xD;
               -  Pregnancy at start of study&#xD;
&#xD;
               -  Immunocompromised patients and those receiving concomitant immunosuppressive&#xD;
                  therapy or other immune modulating drugs including chronic steroid treatment.&#xD;
&#xD;
               -  Bleeding disorders including haemophilia and thrombocytopenia or treatment with&#xD;
                  anticoagulants(Due to risk of intramuscular hematoma after injection)&#xD;
&#xD;
               -  Must not have received vaccination with attenuated pathogens in the 4 weeks&#xD;
                  leading up to study. (Measles, mumps, rubella, yellow fever, rotavirus, BCG,&#xD;
                  typhoid)&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <verification_date>August 2018</verification_date>
  <study_first_submitted>August 10, 2018</study_first_submitted>
  <study_first_submitted_qc>August 10, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">August 15, 2018</study_first_posted>
  <last_update_submitted>August 10, 2018</last_update_submitted>
  <last_update_submitted_qc>August 10, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">August 15, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>PHTS</keyword>
  <keyword>PTEN</keyword>
  <keyword>Vaccination</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hamartoma</mesh_term>
    <mesh_term>Neoplasms</mesh_term>
    <mesh_term>Hamartoma Syndrome, Multiple</mesh_term>
    <mesh_term>Syndrome</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

